Roflumilast prevented tissue damage caused by lipopolysaccharide-induced sepsis via anti-inflammatory action

Demet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın · 2026

Read Roflumilast prevented tissue damage caused by lipopolysaccharide-induced sepsis via anti-inflammatory action by Demet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350653.txt.

Description

Demet Yalçın Kehribar and co-authors tested the lung drug roflumilast against sepsis like injury in rats in 2026. Sepsis, a runaway response to infection, damages many organs, and a bacterial toxin is a standard way to model it in animals.

Rats given the toxin showed high inflammation markers and harm to liver, kidney, and other tissues. A lower drug dose did nothing clear, but the higher dose cut inflammation signals, eased tissue damage, and lowered a kidney injury marker. The dose contrast is the story: protection appeared only at the stronger dose, a caution for any move toward patients.

Catalog record

CREATORDemet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23021
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0350653

Browse the full library · About the Tower of Babel